Flynn James E 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 08:57 am Sale |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 0 0.000% |
-5,312,733 (Position Closed) |
Filing |
| 2024-02-12 5:33 pm Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 5,312,733 7.150% |
938,689 (+21.46%) |
Filing |
| 2023-09-21 4:55 pm Purchase |
2023-09-14 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 4,374,044 5.890% |
1,991,044 (+83.55%) |
Filing |
| 2023-02-10 10:05 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 2,383,000 3.560% |
-1,130,756 (-32.18%) |
Filing |
| 2021-12-03 3:07 pm Purchase |
2021-11-29 | 13G | Kura Oncology, Inc. KURA |
Flynn James E | 3,513,756 5.280% |
3,513,756 (New Position) |
Filing |